SCIENCE

Pipeline

Partnership

NEWS & PRESS

pressReleases

newsMedia

CAREERS

Career Openings

WE DISCOVER AND DEVELOP NOVEL AND

DIFFERENTIATED THERAPIES IN CANCER AND BEYOND

ADDRESS UNMET MEDICAL NEEDS FOR PATIENTS IN CHINA AND GLOBALLY

Founded in 2016, we have established a robust in-house R&D engine underpinned by an oustanding discovery team and multi-dimensional discovery platform. We have strategically designed and developed a rich pipeline of 10+ small molecule programs focused on oncology.

01---

Founders

-------------------------------------------------

Our company was founded by a group of experiened drug hunters with strong passion, proven track records in drug discovery, and rich experience in managing multiple large R&D organizations.

Dr. Yao-Chang Xu

Founder & CEO

Dr. Yao-Chang Xu

Founder & CEO

Dr. Yao-Chang Xu has more than 25 years of drug dis...

Dr. Hongping Yu

Co-founder, SVP of Chemistry

Dr. Hongping Yu

Co-founder, SVP of Chemistry

Dr. Hongping Yu has worked in drug discovery and de...

Dr. Zhui Chen

Co-founder, SVP of Biology

Dr. Zhui Chen

Co-founder, SVP of Biology

Dr. Zhui Chen is a seasoned biologist and drug hunt...

Our Scientific Focus

small molecule precision oncology & immuno-oncology therapies

Our Pipeline

Consists of a broad range of small-molecule
precision-oncology and immuno-oncology product candidates

Partnership

We have established and continue to explore broad partnership

and collaboration with industry and academic leaders

News & Press

bobapp下载地址_bob客户端下载_bob直播平台 Completes Dosing of the First ...

2 December, 2021, Shanghai – bobapp下载地址_bob客户端下载_bob直播平台 Co., Ltd. (“bobapp下载地址_bob客户端下载_bob直播平台” hereafter) today ...

bobapp下载地址_bob客户端下载_bob直播平台 Completes Dosing of the First ...

17 November, 2021, Shanghai – bobapp下载地址_bob客户端下载_bob直播平台 Co., Ltd. (“bobapp下载地址_bob客户端下载_bob直播平台” hereafter) today...

Abbisko’s Partner X4 Pharmaceuticals Completes Enro...

3 November, 2021, Shanghai—bobapp下载地址_bob客户端下载_bob直播平台 Co., Ltd. (Stock Code: 2256.HK, “Abbisko” hereafter) ...

bobapp下载地址_bob客户端下载_bob直播平台 R&D and Manufacturing Facility...

bobapp下载地址_bob客户端下载_bob直播平台 Co., Ltd. (“bobapp下载地址_bob客户端下载_bob直播平台” hereafter) has recently entered into a contrac...

bobapp下载地址_bob客户端下载_bob直播平台 Obtained Clinical Trial Approv...

25 October, 2021, Shanghai – bobapp下载地址_bob客户端下载_bob直播平台 Co., Ltd., a subsidiary of Abbisko Cayman Limited (...

bobapp下载地址_bob客户端下载_bob直播平台 Announces the IND Approval by ...

October 19, 2021, Shanghai – bobapp下载地址_bob客户端下载_bob直播平台 Co., Ltd. (“Abbisko” hereafter) today is pleased to...

VISION & MISSION

We aspire to become a leading biopharmaceutical company to discover and develop novel and differentiated therapies in cancer and beyond, addressing critical unmet needs for patients in China and globally.

Investors

Since our establishment, we have completed four rounds of financing led by blue-chip investors. Our investor base is a testament to our capabilities and provides strong financial supports and industry insights to our future success.